Article Listing - EC PARLIAMENT TO VIEW DRUG SYSTEM

EC PHARMA MARKET FORECASTS TO 1996

27 April 1992

The European Community pharmaceutical market is expected to continue growing over the next five years at a rate in excess...

PROJECT REVIEW FROM NOVO NORDISK

27 April 1992

Highlighting its ongoing R&D in its recently released annual report for 1991, Denmark's Novo Nordisk notes that it intends to...

MEIJI MILK PRODS TEST-MARKETING PREGNANCY TEST

27 April 1992

Meiji Milk Products of Japan has begun test-marketing a pregnancy test which is produced by Ortho Pharmaceutical Corp of the...

NEUTOGENA ACQUIRES INTEREST IN CELLEGY

27 April 1992

Neutrogena Corp has acquired a minority interest in Cellegy Pharmaceuticals, a dermatological products R&D company. Full terms of the agreement...

CONTROVERSIAL ALLERGY THERAPIES

27 April 1992

A report from the UK Royal College of Physicians concludes that many of the claims made for the efficacy of...

CAPOTEN CUTS MORTALITY IN SAVE

27 April 1992

Bristol-Myers Squibb's angiotensin converting enzyme inhibitor product Capoten (captopril) reduces mortality by 17% in post-myocardial infarct patients without overt heart...

STOCK MARKET COMMENTARY: NEW YORK

27 April 1992

NEW YORK: experienced a triple-witching hour ahead of the Easter weekend, which pushed the Dow Jones to a new high,...

GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR

27 April 1992

Good sales growth was experienced by the major US pharmaceutical companies announcing results for the first quarter of 1992 in...

JAPAN'S PROJECTED 1992 MEDICAL COSTS

27 April 1992

An increase of 6.9% to 23,170 billion yen ($172.62 billion) is expected in Japan's medical costs for the current year,...

ROBERTS TO MARKET J&J'S SUPPRELIN

27 April 1992

Roberts Pharmaceutical has ob-tained exclusive worldwide rights to Johnson & Johnson's newly-approved orphan drug Supprelin (histrelin) for the treatment of...

Showing 94381-94390 of 95582 articles